A_significant_association_of_Ha-ras_p21_in_neuroblastoma_cells_with_patient_prognosis._A_retrospective_study_of_103_cases._To_evaluate_biologic_characteristics_of_neuroblastoma,_the_authors_examined_the_expression_of_Ha-ras_gene_(Ha-ras_p21)_in_103_primary_tumors_obtained_at_the_time_of_diagnosis._Higher_expression_of_the_Ha-ras_p21_in_tumor_cells_showed_a_significant_association_with_lower_clinical_stage_of_the_tumor_at_diagnosis_(chi-square_=_35.418,_degrees_of_freedom_df_=_9,_P_less_than_0.001)_and_survival_of_the_patients_(chi-square_=_37.111,_df_=_3,_P_less_than_0.001)._Thirty-six_(84%)_of_43_patients_with_decreased_Ha-ras_p21_expression_died_of_aggressive_disease._The_Ha-ras_DNA_was_examined_in_the_32_tumors_by_Southern_blot_analysis._Neither_augmentation_nor_deletion_of_the_Ha-ras_DNA_was_observed._Amplification_of_the_N-myc_DNA_was_also_examined_in_43_cases_in_comparison_with_Ha-ras_p21_expression._N-myc_amplification_was_detected_in_12_(55%)_of_22_patients_who_died,_and_19_(86%)_of_the_22_patients_showed_a_low_expression_of_the_Ha-ras_p21_in_tumor_cells._Eighteen_(86%)_of_21_survivors_showed_a_high_expression_of_the_Ha-ras_p21._The_expression_of_Ha-ras_p21_was_thought_to_be_a_clinically_important_marker_for_prognosis_in_children_with_neuroblastoma.